Related Experiment Video
Updated: Jun 10, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Efforts to prevent and halt autoimmune beta cell destruction
Michael J Haller1, Mark A Atkinson, Desmond A Schatz
1Division of Endocrinology, Department of Pediatrics, University of Florida, PO Box 100296, Gainesville, FL 32610, USA. hallemj@peds.ufl.edu
Abstract:
Despite improvements in understanding of the natural history of type 1 diabetes (T1D), an intervention capable of consistently and safely preventing or reversing the disease has not been developed. The inability to cure this disorder is largely because of the complex pathophysiology of T1D, continued struggles to identify its precise etiologic triggers, and voids in understanding of the immunologic mechanisms that specifically target pancreatic beta cells. Rapidly improving technologies for managing T1D require critical discussions about equipoise, especially when considering interventions deemed high risk in terms of their safety. This article reviews the conceptual basis for prevention versus intervention trials in settings of T1D, past experiences of clinical trials studying these purposes, and controversial issues regarding disease interdiction, and seeks to provide a roadmap for future efforts to cure this disorder.
Insights
Developing a cure for type 1 diabetes (T1D) remains challenging due to its complex nature and immune system
Area of Science:
- Immunology
- Endocrinology
- Clinical Trials
Background:
- Type 1 diabetes (T1D) pathophysiology is complex, with unclear triggers and immune mechanisms targeting pancreatic beta cells.
- Despite advances in T1D natural history understanding, safe and effective prevention or reversal interventions are lacking.
Purpose of the Study:
- To review the conceptual basis of T1D prevention and intervention trials.
- To examine past clinical trial experiences and controversial issues in T1D interdiction.
- To propose a roadmap for future T1D cure research.
Main Methods:
- Review of conceptual frameworks for T1D prevention and intervention.
- Analysis of historical clinical trial data in T1D.
- Discussion of safety and ethical considerations in T1D research.
Main Results:
- No consistently safe and effective intervention to prevent or reverse T1D has been developed.
- Understanding of T1D etiology and immunologic targets remains incomplete.
- Technological advancements in T1D management necessitate careful evaluation of high-risk interventions.
Conclusions:
- Future T1D research requires a strategic roadmap to address knowledge gaps and guide clinical efforts.
- Critical evaluation of trial equipoise and intervention safety is paramount.
- Further investigation into T1D's complex pathophysiology is essential for developing a cure.
More Related Videos
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology

